Participate in migraines Clinical Trial Today

Active and recruiting trials

  • The C-BEOND Study is a Phase 3 study using Dysport® for those with chronic migraines. Approximately 650 participants are expected to take part in North America and Europe.

    For more information, please visit clinicaltrials.gov.

    If you are interested in participating, please contact VEtten@gengepartners.com

  • The E-BEOND Study is a Phase 3 study using Dysport® for those with episodic migraines. Approximately 650 participants are expected to take part in North America and Europe.

    For more information, please visit clinicaltrials.gov.

    If you are interested in participating, please contact YBenchaar@gengepartners.com

Active but not recruiting trials

  • A non-interventional study to describe the burden of illness and treatment patterns in patients with migraine.

    Closed for recruitment

Upcoming trials

  • Real world study with participants treated with UbrogepanT.

    For more information, please contact Vincent VEtten@gengepartners.com

  • More info to come soon!

If you would like to hear about more about our current or upcoming neurological clinical trials in Montreal please contact us at: info@gengepartners.com

“If we’re not in the beginning for rare disease, we may simply be too late for our patients to get the benefit of these new therapies.”

-Angela Genge

  • Our mission

    To improve patient health and well-being by conducting cutting-edge clinical research. We strive to foster a culture of innovation, collaboration, and excellence in all aspects of our research, and to contribute to the global effort to improve healthcare for all.

  • Our vision

    To be a leading force in advancing medical knowledge and improving patient care through innovative and ethical clinical research

  • Our future

    Genge Partners will continue to be at the forefront of clinical research, utilizing the latest technologies and methodologies to bring new treatments and therapies to patients in need. Our commitment to patient safety, scientific rigor, and ethical conduct will remain steadfast, as we work to improve healthcare for all and make a lasting impact on the field of medicine.

Our facility:

Genge Partners @ Glen
5100 Boul. de Maisonneuve Ouest, 6th floor
Montreal, QC H4A 3TA

 

© 2022 Genge Partners Inc. All rights reserved | Confidentiality policy